Maxigen Biotech Inc (1783) — Cash Flow-to-Debt Ratio
Maxigen Biotech Inc (1783) has a Cash Flow-to-Debt Ratio of 0.22x as of March 2026, meaning its operating cash flow of NT$79.84 Million could theoretically repay 0% of its total liabilities (NT$364.27 Million) in one year. See Maxigen Biotech Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Maxigen Biotech Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Maxigen Biotech Inc across 17 annual periods. Also explore Maxigen Biotech Inc (1783) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Maxigen Biotech Inc (2009–2025)
Year-by-year debt coverage analysis for Maxigen Biotech Inc. For market capitalisation and broader financial context, see 1783 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.82x | NT$290.22 Million | NT$355.54 Million | ▼ -43.2% |
| 2024 | 1.44x | NT$298.22 Million | NT$207.36 Million | ▲ +10.8% |
| 2023 | 1.30x | NT$171.20 Million | NT$131.88 Million | ▼ -26.4% |
| 2022 | 1.76x | NT$268.34 Million | NT$152.07 Million | ▲ +85.3% |
| 2021 | 0.95x | NT$117.59 Million | NT$123.47 Million | ▲ +23.2% |
| 2020 | 0.77x | NT$74.39 Million | NT$96.24 Million | ▲ +173.6% |
| 2019 | 0.28x | NT$94.42 Million | NT$334.17 Million | ▼ -51.6% |
| 2018 | 0.58x | NT$170.58 Million | NT$292.48 Million | ▲ +335.9% |
| 2017 | 0.13x | NT$41.18 Million | NT$307.73 Million | ▲ +21.8% |
| 2016 | 0.11x | NT$34.72 Million | NT$316.04 Million | ▲ +133.8% |
| 2015 | -0.32x | NT$-109.85 Million | NT$338.38 Million | ▼ -207.0% |
| 2014 | -0.11x | NT$-14.45 Million | NT$136.65 Million | ▲ +40.3% |
| 2013 | -0.18x | NT$-22.34 Million | NT$126.04 Million | ▼ -221.4% |
| 2012 | 0.15x | NT$17.53 Million | NT$120.10 Million | ▲ +122.4% |
| 2011 | -0.65x | NT$-76.64 Million | NT$117.40 Million | ▼ -33.8% |
| 2010 | -0.49x | NT$-16.76 Million | NT$34.37 Million | ▼ -177.2% |
| 2009 | 0.63x | NT$19.27 Million | NT$30.51 Million | — |